Veracyte (VCYT) CEO has 19,455 shares withheld to cover taxes

Rhea-AI Filing Summary

VERACYTE, INC. Chief Executive Officer Marc Stapley reported a tax-related share disposition. On March 2, 2026, 19,455 shares of common stock were withheld to satisfy tax obligations tied to vesting restricted stock units at a reference price of $36.01 per share. Following this withholding, he directly owns 403,077 shares of Veracyte common stock. The footnote clarifies this was not an open-market sale but a tax-withholding transaction.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Stapley Marc

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	19,455	$36.01	$701K

Holdings After Transaction: Common Stock — 403,077 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stapley Marc

(Last) (First) (Middle)

6000 SHORELINE COURT

SUITE 300

(Street)

SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026		F(1)		19,455	D	$36.01	403,077	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on March 2, 2026 and does not represent a sale.

Remarks:

	/s/ Jonathan Wygant, as attorney-in-fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Veracyte (VCYT) report for CEO Marc Stapley?

Veracyte CEO Marc Stapley reported a tax-withholding share disposition. On March 2, 2026, 19,455 shares of common stock were withheld to cover tax obligations from vesting restricted stock units, according to the Form 4, rather than being sold on the open market.

How many Veracyte shares were withheld for Marc Stapley’s taxes and at what price?

Veracyte withheld 19,455 shares for Marc Stapley’s tax obligations. The reference price listed was $36.01 per share. These shares were used to satisfy tax withholding related to vesting restricted stock units, not as a discretionary sale into the market.

Does the Veracyte Form 4 for Marc Stapley represent an open-market stock sale?

No, the Veracyte Form 4 does not represent an open-market sale. The filing states the 19,455 shares were withheld solely to satisfy Marc Stapley’s tax withholding obligations when restricted stock units vested, and the footnote explicitly says this transaction does not represent a sale.

How many Veracyte shares does CEO Marc Stapley hold after the reported transaction?

After the transaction, Marc Stapley directly holds 403,077 Veracyte shares. This total reflects his ownership following the withholding of 19,455 shares to cover tax obligations tied to vesting restricted stock units, as shown in the Form 4 filing.

What transaction code is used in Marc Stapley’s Veracyte Form 4 and what does it mean?

The Form 4 uses transaction code “F” for Marc Stapley’s transaction. Code F indicates payment of a tax liability or exercise price by delivering securities. Here it reflects shares withheld to satisfy tax obligations from vesting restricted stock units, rather than a typical buy or sell.